Right now, vaccines are still claiming the majority of public attention – but safe and effective treatments are a critical weapon in our battle against COVID-19, offering hope of turning a potentially fatal virus into an inherently manageable one.
Although only a few treatments have been approved for use so far, the COVID-19 therapy development space is a hive of activity, with numerous manufacturers working on repurposing existing drugs and innovating new treatments.
In this article, we explore the focus for COVID-19 treatment development, the current COVID-19 treatment landscape and, drawing on real-world data from Ipsos’ new COVID-19 Therapy Monitor, how treatments are being used in real-world clinical practice.
Trust and the reputation of the pharmaceutical industry: has the pandemic made a difference?
Since the global pandemic, the public have had more exposure to the power of pharma companies to improve and save lives. The sector has also been exposed to an unprecedented level of mainstream media coverage. So the big question is; has this has led to a heightened degree of trust?
A survey in eight countries about HPV reveals over a quarter of surveyed parents from across Europe are unaware of HPV
MSD commissioned Ipsos to run a survey to support speakers at the European Week Against Cancer, taking place from 25 – 31 May 2022. The findings demonstrate the need to further boost HPV awareness and knowledge, to lead to greater vaccine uptake and ultimately lower the prevalence of cancer-causing HPV.